Expressive Writing for Stress Management in Cancer Survivors

This study is looking at whether expressive writing can help cancer survivors manage stress. Cancer survivors often face stress due to concerns about family, finances, and treatment side effects. This study will compare two groups: one group will read positive messages and write about positive experiences, while the other group will read neutral messages and write about neutral topics. Researchers want to see how feasible this virtual study is and if these writing activities can help improve your mood and health. You might be able to join if you are at least 18, were diagnosed with cancer within the last 3 years, can speak and read English, and have internet access. The study aims to measure how many people participate, complete the study, and stick with the writing activities over one month.

Study design
This is an interventional study with 414 planned participants. Participants will be randomly assigned to one of two groups.
What's involved
You would complete questionnaires about your mood, health, and income at the start, and then at 1, 3, and 6 months. You would also spend 30 minutes once a week for 3 weeks reading messages and writing essays.
Compensation
Not stated in the trial record.
Follow-up
Your responses and adherence to the intervention will be measured at 1 month. Questionnaires about your mood, health, and income will be collected up to 6 months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT04776941

Expressive Writing for the Management of Stress in Cancer Survivors

Recruiting
NAAges 18+InterventionalSupportive care
M.D. Anderson Cancer Center
~414 participants
Updated 2026-08-14 on ClinicalTrials.gov
What's tested:Behavioral InterventionQuality-of-Life AssessmentQuestionnaire Administration

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Participant response rate
Measured over 1 month
+2 more outcomes measured
Hematopoietic and Lymphoid Cell Neoplasm
Malignant Solid Neoplasm

NCT04776941

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • M D Anderson Cancer Center

    Houston, Texasstudy coordinator listed

    Recruiting

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

  • Qian Lu · PRINCIPAL_INVESTIGATOR · M.D. Anderson Cancer Center

Opens a ready-to-send draft in your own email app — review before sending.

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

At least 18 years old
Have a diagnosis of cancer within the past 3 years
Are able to speak and read in English
Have access to a computer or smart phone with internet connection
All disease sites and all cancer stages are eligible for enrollment

Exclusion

Inability to provide informed consent
Non-English speakers will be excluded because this is a feasibility study that will enroll only a limited number of participants
  • Participant response rate1 month
  • Study completion rate1 month
  • Intervention adherence rate1 month